TheEdgeResearch
Home / Stocks / AVCR.V

Avricore Health Inc. (AVCR.V)

TSXV Healthcare Medical - Diagnostics & Research
$0.06 ▲ +0.00%
Market Cap
$5.6M
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
0.32
52-Wk Range
0.045-0.1
CEO
Rodger Seccombe
Country
CA
Currency
CAD

Avricore Health Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.06, up 0.00% on the session, giving a market capitalisation of $5.6M. Its beta of 0.32 implies it has historically moved less than the broad market.

Company profile
Exchange
Toronto Stock Exchange Ventures
Employees
26
IPO date
2013-03-20
Headquarters
Vancouver, BC, CA
About Avricore Health Inc.

Avricore Health Inc. operates within Canada, specializing in health data management and point-of-care technological solutions. Their primary offering is HealthTab, a precise, laboratory-quality diagnostic testing system designed for use in pharmacies. This enterprise maintains key alliances with prominent organizations such as Shoppers Drug Marts and Abbott. Established in 1996 and headquartered in Vancouver, Canada, the company previously operated as Vanc Pharmaceuticals Inc., adopting its current name, Avricore Health Inc., in October 2018.

Comparable companies

Avricore Health Inc. is most often compared with the following Healthcare names:

APS.TOCANB.VCDVA.CNKNE.VMUSH.VMVMD.CNRVV.CNTELO.VTGIF.CNTHRM.V
More research on AVCR.V
AVCR.V technical analysis AVCR.V TheEdge Score Compare against peers
Open full interactive analysis & DCF →